Category Archives: nanotechnology

Nanocellulose films made with liquid-phase fabrication method

I always appreciate a reference to Star Trek and three-dimensional chess was one of my favourite concepts. You’ll find that and more in a May 19, 2020 news item on Nanowerk,

Researchers at The Institute of Scientific and Industrial Research at Osaka University [Japan] introduced a new liquid-phase fabrication method for producing nanocellulose films with multiple axes of alignment. Using 3D-printing methods for increased control, this work may lead to cheaper and more environmentally friendly optical and thermal devices.

Ever since appearing on the original Star Trek TV show in the 1960s, the game of “three-dimensional chess” has been used as a metaphor for sophisticated thinking. Now, researchers at Osaka University can say that they have added their own version, with potential applications in advanced optics and inexpensive smartphone displays.

It’s not exactly three-dimensional chess but this nanocellulose film was produced by 3D printing methods,

Caption: Developed multiaxis nanocellulose-oriented film. Credit: Osaka University

A May 20, 2020 Osaka University press release (also on EurekAlert but dated May 19, 2020), which originated the news item, provides more detail,

Many existing optical devices, including liquid-crystal displays (LCDs) found in older flat-screen televisions, rely on long needle-shaped molecules aligned in the same direction. However, getting fibers to line up in multiple directions on the same device is much more difficult. Having a method that can reliably and cheaply produce optical fibers would accelerate the manufacture of low-cost displays or even “paper electronics”–computers that could be printed from biodegradable materials on demand.

Cellulose, the primary component of cotton and wood, is an abundant renewable resource made of long molecules. Nanocelluloses are nanofibers made of uniaxially aligned cellulose molecular chains that have different optical and heat conduction properties along one direction compared to the another.

In newly published research from the Institute of Scientific and Industrial Research at Osaka University, nanocellulose was harvested from sea pineapples, a kind of sea squirt. They then used liquid-phase 3D-pattering, which combined the wet spinning of nanofibers with the precision of 3D-printing. A custom-made triaxial robot dispensed a nanocellulose aqueous suspension into an acetone coagulation bath.

“We developed this liquid-phase three-dimensional patterning technique to allow for nanocellulose alignment along any preferred axis,” says first author Kojiro Uetani. The direction of the patterns could be programmed so that it formed an alternating checkerboard pattern of vertically- and horizontally-aligned fibers.

To demonstrate the method, a film was sandwiched between two orthogonal polarizing films. Under the proper viewing conditions, a birefringent checkerboard pattern appeared. They also measured the thermal transfer and optical retardation properties.

“Our findings could aid in the development of next-generation optical materials and paper electronics,” says senior author Masaya Nogi. “This could be the start of bottom-up techniques for building sophisticated and energy-efficient optical and thermal materials.”

Here’s a link to and a citation for the paper,

Checkered Films of Multiaxis Oriented Nanocelluloses by Liquid-Phase Three-Dimensional Patterning by Kojiro Uetani, Hirotaka Koga and Masaya Nogi. Nanomaterials 2020, 10(5), 958; DOI: Published: 18 May 2020

This is an open access paper.

Preventing warmed-up vaccines from becoming useless

One of the major problems with vaccines is that they need to be refrigerated. (The Nanopatch, which additionally wouldn’t require needles or syringes, is my favourite proposed solution and it comes from Australia.) This latest research into making vaccines more long-lasting is from the UK and takes a different approach to the problem.

From a June 8, 2020 news item on,

Vaccines are notoriously difficult to transport to remote or dangerous places, as they spoil when not refrigerated. Formulations are safe between 2°C and 8°C, but at other temperatures the proteins start to unravel, making the vaccines ineffective. As a result, millions of children around the world miss out on life-saving inoculations.

However, scientists have now found a way to prevent warmed-up vaccines from degrading. By encasing protein molecules in a silica shell, the structure remains intact even when heated to 100°C, or stored at room temperature for up to three years.

The technique for tailor-fitting a vaccine with a silica coat—known as ensilication—was developed by a Bath [University] team in collaboration with the University of Newcastle. This pioneering technology was seen to work in the lab two years ago, and now it has demonstrated its effectiveness in the real world too.

Here’s the lead researcher describing her team’s work

Ensilication: success in animal trials from University of Bath on Vimeo.

A June 8, 2020 University of Bath press release (also on EurekAlert) fills in more details about the research,

In their latest study, published in the journal Scientific Reports, the researchers sent both ensilicated and regular samples of the tetanus vaccine from Bath to Newcastle by ordinary post (a journey time of over 300 miles, which by post takes a day or two). When doses of the ensilicated vaccine were subsequently injected into mice, an immune response was triggered, showing the vaccine to be active. No immune response was detected in mice injected with unprotected doses of the vaccine, indicating the medicine had been damaged in transit.

Dr Asel Sartbaeva, who led the project from the University of Bath’s Department of Chemistry, said: “This is really exciting data because it shows us that ensilication preserves not just the structure of the vaccine proteins but also the function – the immunogenicity.”

“This project has focused on tetanus, which is part of the DTP (diphtheria, tetanus and pertussis) vaccine given to young children in three doses. Next, we will be working on developing a thermally-stable vaccine for diphtheria, and then pertussis. Eventually we want to create a silica cage for the whole DTP trivalent vaccine, so that every child in the world can be given DTP without having to rely on cold chain distribution.”

Cold chain distribution requires a vaccine to be refrigerated from the moment of manufacturing to the endpoint destination.

Silica is an inorganic, non-toxic material, and Dr Sartbaeva estimates that ensilicated vaccines could be used for humans within five to 15 years. She hopes the technology to silica-wrap proteins will eventually be adopted to store and transport all childhood vaccines, as well as other protein-based products, such as antibodies and enzymes.

“Ultimately, we want to make important medicines stable so they can be more widely available,” she said. “The aim is to eradicate vaccine-preventable diseases in low income countries by using thermally stable vaccines and cutting out dependence on cold chain.”

Currently, up to 50% of vaccine doses are discarded before use due to exposure to suboptimal temperatures. According to the World Health Organisation (WHO), 19.4 million infants did not receive routine life-saving vaccinations in 2018.

Here’s a link to and a citation for the paper,

Ensilicated tetanus antigen retains immunogenicity: in vivo study and time-resolved SAXS characterization by A. Doekhie, R. Dattani, Y-C. Chen, Y. Yang, A. Smith, A. P. Silve, F. Koumanov, S. A. Wells, K. J. Edler, K. J. Marchbank, J. M. H. van den Elsen & A. Sartbaeva. Scientific Reports volume 10, Article number: 9243 (2020) DOI: Published 08 June 2020

This paper is open access

Nanopatch update

I tend to lose track as a science gets closer to commercialization since the science news becomes business news and I almost never scan that sector. It’s been about two-and-half years since I featured research that suggested Nanopatch provided more effective polio vaccination than the standard needle and syringe method in a December 20, 2017 post. The latest bits of news have an interesting timeline.

March 2020

Mark Kendal (Wikipedia entry) is the researcher behind the Nanopatch. He’s interviewed in a March 5, 2020 episode (about 20 mins.) in the Pioneers Series (bankrolled by Rolex [yes, the watch company]) on Coincidentally or not, a new piece of research funded by Vaxxas (the nanopatch company founded by Mark Kendall; on the website you will find a ‘front’ page and a ‘Contact us’ page only) was announced in a March 17, 2020 news item on,

Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication in the journal PLoS Medicine of groundbreaking clinical research indicating the broad immunological and commercial potential of Vaxxas’ novel high-density microarray patch (HD-MAP). Using influenza vaccine, the clinical study of Vaxxas’ HD-MAP demonstrated significantly enhanced immune response compared to vaccination by needle/syringe. This is the largest microarray patch clinical vaccine study ever performed.

“With vaccine coated onto Vaxxas HD-MAPs shown to be stable for up to a year at 40°C [emphasis mine], we can offer a truly differentiated platform with a global reach, particularly into low and middle income countries or in emergency use and pandemic situations,” said Angus Forster, Chief Development and Operations Officer of Vaxxas and lead author of the PLoS Medicine publication. “Vaxxas’ HD-MAP is readily fabricated by injection molding to produce a 10 x 10 mm square with more than 3,000 microprojections that are gamma-irradiated before aseptic dry application of vaccine to the HD-MAP’s tips. All elements of device design, as well as coating and QC, have been engineered to enable small, modular, aseptic lines to make millions of vaccine products per week.”

The PLoS publication reported results and analyses from a clinical study involving 210 clinical subjects [emphasis mine]. The clinical study was a two-part, randomized, partially double-blind, placebo-controlled trial conducted at a single Australian clinical site. The clinical study’s primary objective was to measure the safety and tolerability of A/Singapore/GP1908/2015 H1N1 (A/Sing) monovalent vaccine delivered by Vaxxas HD-MAP in comparison to an uncoated Vaxxas HD-MAP and IM [intramuscular] injection of a quadrivalent seasonal influenza vaccine (QIV) delivering approximately the same dose of A/Sing HA protein. Exploratory outcomes were: to evaluate the immune responses to HD-MAP application to the forearm with A/Sing at 4 dose levels in comparison to IM administration of A/Sing at the standard 15 μg HA per dose per strain, and to assess further measures of immune response through additional assays and assessment of the local skin response via punch biopsy of the HD-MAP application sites. Local skin response, serological, mucosal and cellular immune responses were assessed pre- and post-vaccination.

Here’s a link to and a citation for the latest ‘nanopatch’ paper,

Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial by Angus H. Forster, Katey Witham, Alexandra C. I. Depelsenaire, Margaret Veitch, James W. Wells, Adam Wheatley, Melinda Pryor, Jason D. Lickliter, Barbara Francis, Steve Rockman, Jesse Bodle, Peter Treasure, Julian Hickling, Germain J. P. Fernando. DOI: PLOS (Public Library of Science) Published: March 17, 2020

This is an open access paper.

May 2020

Two months later, Merck, an American multinational pharmaceutical company, showed some serious interest in the ‘nanopatch’. A May 28, 2020 article by Chris Newmarker for announces the news (Note: Links have been removed),

Merck has exercised its option to use Vaxxas‘ High Density Microarray Patch (HD-MAP) platform as a delivery platform for a vaccine candidate, the companies announced today [Thursday, May 28, 2020].

Also today, Vaxxas announced that German manufacturing equipment maker Harro Höfliger will help Vaxxas develop a high-throughput, aseptic manufacturing line to make vaccine products based on Vaxxas’ HD-MAP technology. Initial efforts will focus on having a pilot line operating in 2021 to support late-stage clinical studies — with a goal of single, aseptic-based lines being able to churn out 5 million vaccine products a week.

“A major challenge in commercializing microarray patches — like Vaxxas’ HD-MAP — for vaccination is the ability to manufacture at industrially-relevant scale, while meeting stringent sterility and quality standards. Our novel device design along with our innovative vaccine coating and quality verification technologies are an excellent fit for integration with Harro Höfliger’s aseptic process automation platforms. Adopting a modular approach, it will be possible to achieve output of tens-of-millions of vaccine-HD-MAP products per week,” Hoey [David L. Hoey, President and CEO of Vaxxas] said.

Vaxxas also claims that the patches can deliver vaccine more efficiently — a positive when people around the world are clamoring for a vaccine against COVID-19. The company points to a recent [March 17, 2020] clinical study in which their micropatch delivering a sixth of an influenza vaccine dose produced an immune response comparable to a full dose by intramuscular injection. A two-thirds dose by HD-MAP generated significantly faster and higher overall antibody responses.

As I noted earlier, this is an interesting timeline.

Final comment

In the end, what all of this means is that there may be more than one way to deal with vaccines and medicines that deteriorate all too quickly unless refrigerated. I wish all of these researchers the best.

Smart film lets windows switch autonomously

This work from Korean research scientists gives me some hope that smart windows will one day be the norm. From a June 2, 2020 Korea Advanced Institute of Science and Technology (KAIST) press release (also on EurekAlert),

Researchers have developed a new easy-to-use smart optical film technology that allows smart window devices to autonomously switch between transparent and opaque states in response to the surrounding light conditions.

The proposed 3D hybrid nanocomposite film with a highly periodic network structure has empirically demonstrated its high speed and performance, enabling the smart window to quantify and self-regulate its high-contrast optical transmittance. As a proof of concept, a mobile-app-enabled smart window device for Internet of Things (IoT) applications has been realized using the proposed smart optical film with successful expansion to the 3-by-3-inch scale. This energy-efficient and cost-effective technology holds great promise for future use in various applications that require active optical transmission modulation.

Flexible optical transmission modulation technologies for smart applications including privacy-protection windows, zero-energy buildings, and beam projection screens have been in the spotlight in recent years. Conventional technologies that used external stimuli such as electricity, heat, or light to modulate optical transmission had only limited applications due to their slow response speeds, unnecessary color switching, and low durability, stability, and safety.

The optical transmission modulation contrast achieved by controlling the light scattering interfaces on non-periodic 2D surface structures that often have low optical density such as cracks, wrinkles, and pillars is also generally low. In addition, since the light scattering interfaces are exposed and not subject to any passivation, they can be vulnerable to external damage and may lose optical transmission modulation functions. Furthermore, in-plane scattering interfaces that randomly exist on the surface make large-area modulation with uniformity difficult.

Inspired by these limitations, a KAIST research team led by Professor Seokwoo Jeon from the Department of Materials Science and Engineering and Professor Jung-Wuk Hong of the Civil and Environmental Engineering Department used proximity-field nanopatterning (PnP) technology that effectively produces highly periodic 3D hybrid nanostructures, and an atomic layer deposition (ALD) technique that allows the precise control of oxide deposition and the high-quality fabrication of semiconductor devices.

The team then successfully produced a large-scale smart optical film with a size of 3 by 3 inches in which ultrathin alumina nanoshells are inserted between the elastomers in a periodic 3D nanonetwork.

This “mechano-responsive” 3D hybrid nanocomposite film with a highly periodic network structure is the largest smart optical transmission modulation film that exists. The film has been shown to have state-of-the-art optical transmission modulation of up to 74% at visible wavelengths from 90% initial transmission to 16% in the scattering state under strain. Its durability and stability were proved by more than 10,000 tests of harsh mechanical deformation including stretching, releasing, bending, and being placed under high temperatures of up to 70°C. When this film was used, the transmittance of the smart window device was adjusted promptly and automatically within one second in response to the surrounding light conditions. Through these experiments, the underlying physics of optical scattering phenomena occurring in the heterogeneous interfaces were identified. Their findings were reported in the online edition of Advanced Science on April 26 [2020]. KAIST Professor Jong-Hwa Shin’s group and Professor Young-Seok Shim at Silla University also collaborated on this project.

Donghwi Cho, a PhD candidate in materials science and engineering at KAIST and co-lead author of the study, said, “Our smart optical film technology can better control high-contrast optical transmittance by relatively simple operating principles and with low energy consumption and costs.”

“When this technology is applied by simply attaching the film to a conventional smart window glass surface without replacing the existing window system, fast switching and uniform tinting are possible while also securing durability, stability, and safety. In addition, its wide range of applications for stretchable or rollable devices such as wall-type displays for a beam projection screen will also fulfill aesthetic needs,” he added.

Here’s an image illustrating how the composite scatters light (I think),

Caption: Design concept of and fabrication procedures for the 3D scatterer. Credit: KAIST

Here’s a link to and a citation for the paper,

High‐Contrast Optical Modulation from Strain‐Induced Nanogaps at 3D Heterogeneous Interfaces by Donghwi Cho, Prof. Young‐Seok Shim, Dr. Jae‐Wook Jung, Sang‐Hyeon Nam, Seokhwan Min, Dr. Sang‐Eon Lee, Youngjin Ham, Prof. Kwangjae Lee, Prof. Junyong Park, Prof. Jonghwa Shin, Prof. Jung‐Wuk Hong, and Prof. Seokwoo Jeon. Advanced Science DOI: First published: 26 April 2020

This paper is open access.

Antiviral, antibacterial surface for reducing spread of infectious diseases

In the past several years, scientists have created antibacterial surfaces by fabricating materials with specific types of nanostructures. According to a May 27, 2020 news item on Nanowerk, scientists have now been able to add antiviral properties (Note: A link has been removed),

The novel coronavirus pandemic has caused an increased demand for antimicrobial treatments that can keep surfaces clean, particularly in health care settings. Although some surfaces have been developed that can combat bacteria, what’s been lacking is a surface that can also kill off viruses.

Now, researchers have found a way to impart durable antiviral and antibacterial properties to an aluminum alloy used in hospitals, according to a report in ACS Biomaterials Science & Engineering (“Antiviral and Antibacterial Nanostructured Surfaces with Excellent Mechanical Properties for Hospital Applications”).

A May 27, 2020 American Chemical Society (ACS) news release (also on EurekAlert), which originated the news item, describes the problem and the proposed solution,

Among other mechanisms, viruses and bacteria can spread when a person touches a site where germs have settled, such as a doorframe, handrail or medical device. A healthy person can often fight off these bugs, but hospital patients can be more vulnerable to infection. The number of hospital-acquired infections has been on the decline in the U.S., but they still cause tens of thousands of deaths every year, according to the U.S. Department of Health and Human Services. Chemical disinfectants or coatings containing hydrophobic compounds, silver ions or copper can reduce infectious contaminants on surfaces, but these treatments don’t last. However, nature has developed its own solutions for battling microorganisms, including microscopic structural features that render some insect wings lethal to bacteria. Scientists have replicated this effect by forming surfaces covered with minute pillars and other shapes that distort and kill bacterial cells. But Prasad Yarlagadda and colleagues wanted to inactivate viruses as well as bacteria, so they set out to generate a novel nanoscale topography on long-lasting, industrially relevant materials.

The team experimented with disks of aluminum 6063, which is used in doorframes, window panels, and hospital and medical equipment. Etching the disks with sodium hydroxide for up to 3 hours changed the initially smooth, hydrophobic surface into a ridged, hydrophilic surface. Bacteria or viruses were then applied to the etched disks. Most of the Pseudomonas aeruginosa and Staphylococcus aureus bacteria were inactivated after 3 hours on the surface, while viability of common respiratory viruses dropped within 2 hours; both results were better than with plastic or smooth aluminum surfaces. The disks retained their effectiveness even after tests designed to mimic hospital wear and tear. The researchers note this is the first report to show combined antibacterial and antiviral properties of a durable, nanostructured surface that has the potential to stop the spread of infections arising from physical surfaces in hospitals. This strategy could be extended to surfaces in other public areas, such as cruise ships, planes and airports, they say. The team is now studying the effects of their nano-textured aluminum surfaces on the novel coronavirus.

This approach reminds me of Sharklet, a company fabricating a material designed to mimic a shark’s skin which is naturally antibacterial due to the nanostructures on its skin (see my September 18, 2014 posting).

More about Sharklet later. First, here’s a link to and a citation for the paper about this latest work,

Antiviral and Antibacterial Nanostructured Surfaces with Excellent Mechanical Properties for Hospital Applications by Jafar Hasan, Yanan Xu, Tejasri Yarlagadda, Michael Schuetz, Kirsten Spann, and Prasad KDV Yarlagadda. ACS Biomater. Sci. Eng. 2020, XXXX, XXX, XXX-XXX DOI: Publication Date:May 7, 2020 Copyright © 2020 American Chemical Society

This paper is behind a paywall.

Business and science: a Sharklet update

You can find the Sharklet website here. I wasn’t able to find any news about recent business deals other than the company’s acquisition by Peaceful Union in May 2017. From a May 17, 2017 Sharklet news release on Business Wire (and on the company website here),

Sharklet Technologies, Inc., a biotechnology company lauded for the creation and commercialization of Sharklet®, the world’s first micro-texture that inhibits bacterial growth on surfaces, has announced that it has completed a financing event led by Peaceful Union, an equity medical device firm in Hangzhou, China. Terms of the transaction were not disclosed.

The acquisition of the company will enable Sharklet Technologies to accelerate the development of Sharklet for medical devices where chemical-free bacterial inhibition is desired as well as high-touch surfaces prone to bacterial contamination. The company also will accelerate development of a newly enhanced wound dressing technology to encourage healing.

Joe Bagan and Mark Spiecker led the transaction structure. “This is an important day for the company and investors,” said Joe Bagan, former board chair, and Mark Spiecker, former CEO. “Our investors will realize a significant transaction while enabling the company to accelerate growth.”

In concert with the investment, Sharklet Technologies founding member, chief technology officer, and Sharklet inventor Dr. Anthony Brennan, will become chairman of the board assuming duties from chairman Joe Bagan and CEO Mark Spiecker.

Interestingly, Bagan and Spiecker are Chief Executive Officer (CEO) and President, respectively at STAQ Pharma. I wonder if there are plans to sell this company too.

Getting back to Sharklet, I found two items of recent origin about business but I cannot speak to the accuracy or trustworthiness of either item. That said, you will find they provide some detail about Sharklet’s new business directions and new business ties.

While Sharklet’s current business associations have a sketchy quality, it seems that’s not unusual in business, especially where new technologies are concerned. For example, the introduction of electricity into homes and businesses was a tumultuous affair as the 2008 book, ‘Power Struggles; Scientific Authority and the Creation of Practical Electricity Before Edison’ by Michael Brian Schiffer makes clear, from the MIT [Massachusetts Institute of Technology] Press ‘Power Struggles’ webpage,

In 1882, Thomas Edison and his Edison Electric Light Company unveiled the first large-scale electrical system in the world to light a stretch of offices in a city. … After laying out a unified theoretical framework for understanding technological change, Schiffer presents a series of fascinating case studies of pre-Edison electrical technologies, including Volta’s electrochemical battery, the blacksmith’s electric motor, the first mechanical generators, Morse’s telegraph, the Atlantic cable, and the lighting of the Capitol dome. Schiffer discusses claims of “practicality” and “impracticality” (sometimes hotly contested) made for these technologies, and examines the central role of the scientific authority—in particular, the activities of Joseph Henry, mid-nineteenth-century America’s foremost scientist—in determining the fate of particular technologies. These emerging electrical technologies formed the foundation of the modern industrial world. Schiffer shows how and why they became commercial products in the context of an evolving corporate capitalism in which conflicting judgments of practicality sometimes turned into power struggles. [emphases mine]

Even given that the book’s focus is pre-Edison electricity, how do you mention Edison himself without even casually mentioning Nikola Tesla and George Westinghouse in the book’s overview? Getting back to my point, emerging technologies do not emerge easily.

Space junk clogs up low-Earth orbit

Arianne Cohen’s May 28, 2020 article for Fast Company concisely sums up the space junk problem and solution (Note: A link has been removed),

Throwing money at problems works in space, too! A paper in the Proceedings of the National Academy of Sciences [PNAS] says that the space debris problem can be fixed once and for all, not by the engineers and scientists who consider space their domain, but with cold, hard cash: about $235,000 per satellite. Such a plan would create financial barriers for smaller organizations.

This looks pretty doesn’t it? hard to believe it’s a representation of the junk yard that floats around the earth.

Caption: A computer-generated image representing space debris as could be seen from high Earth orbit. The two main debris fields are the ring of objects in geosynchronous Earth orbit and the cloud of objects in low Earth orbit. Credit: NASA

For those who like a little more detail, a May 25, 2020 University of Colorado at Boulder news release (also on EurekAlert) presents the idea for orbital user fees as a means of limiting the amount of space junk,

Space is getting crowded. Aging satellites and space debris crowd low-Earth orbit, and launching new satellites adds to the collision risk. The most effective way to solve the space junk problem, according to a new study, is not to capture debris or deorbit old satellites: it’s an international agreement to charge operators “orbital-use fees” for every satellite put into orbit.

Orbital use fees would also increase the long-run value of the space industry, said economist Matthew Burgess, a CIRES [Cooperative Institute for Research in Environmental Sciences] Fellow and co-author of the new paper. By reducing future satellite and debris collision risk, an annual fee rising to about $235,000 per satellite would quadruple the value of the satellite industry by 2040, he and his colleagues concluded in a paper published today in the Proceedings of the National Academy of Sciences.

“Space is a common resource, but companies aren’t accounting for the cost their satellites impose on other operators when they decide whether or not to launch,” said Burgess, who is also an assistant professor in Environmental Studies and an affiliated faculty member in Economics at the University of Colorado Boulder. “We need a policy that lets satellite operators directly factor in the costs their launches impose on other operators.”

Currently, an estimated 20,000 objects–including satellites and space debris–are crowding low-Earth orbit. It’s the latest Tragedy of the Commons, the researchers said: Each operator launches more and more satellites until their private collision risk equals the value of the orbiting satellite.

So far, proposed solutions have been primarily technological or managerial, said Akhil Rao, assistant professor of economics at Middlebury College and the paper’s lead author. Technological fixes include removing space debris from orbit with nets, harpoons, or lasers. Deorbiting a satellite at the end of its life is a managerial fix.

Ultimately, engineering or managerial solutions like these won’t solve the debris problem because they don’t change the incentives for operators. For example, removing space debris might motivate operators to launch more satellites–further crowding low-Earth orbit, increasing collision risk, and raising costs. “This is an incentive problem more than an engineering problem. What’s key is getting the incentives right,” Rao said.

A better approach to the space debris problem, Rao and his colleagues found, is to implement an orbital-use fee–a tax on orbiting satellites. “That’s not the same as a launch fee,” Rao said, “Launch fees by themselves can’t induce operators to deorbit their satellites when necessary, and it’s not the launch but the orbiting satellite that causes the damage.”

Orbital-use fees could be straight-up fees or tradeable permits, and they could also be orbit-specific, since satellites in different orbits produce varying collision risks. Most important, the fee for each satellite would be calculated to reflect the cost to the industry of putting another satellite into orbit, including projected current and future costs of additional collision risk and space debris production–costs operators don’t currently factor into their launches. “In our model, what matters is that satellite operators are paying the cost of the collision risk imposed on other operators,” said Daniel Kaffine, professor of economics and RASEI Fellow at the University of Colorado Boulder and co-author on the paper.

And those fees would increase over time, to account for the rising value of cleaner orbits. In the researchers’ model, the optimal fee would rise at a rate of 14 percent per year, reaching roughly $235,000 per satellite-year by 2040.

For an orbital-use fee approach to work, the researchers found, all countries launching satellites would need to participate–that’s about a dozen that launch satellites on their own launch vehicles and more than 30 that own satellites. In addition, each country would need to charge the same fee per unit of collision risk for each satellite that goes into orbit, although each country could collect revenue separately. Countries use similar approaches already in carbon taxes and fisheries management.

In this study, Rao and his colleagues compared orbital-use fees to business as usual (that is, open access to space) and to technological fixes such as removing space debris. They found that orbital use fees forced operators to directly weigh the expected lifetime value of their satellites against the cost to industry of putting another satellite into orbit and creating additional risk. In other scenarios, operators still had incentive to race into space, hoping to extract some value before it got too crowded.

With orbital-use fees, the long-run value of the satellite industry would increase from around $600 billion under the business-as-usual scenario to around $3 trillion, researchers found. The increase in value comes from reducing collisions and collision-related costs, such as launching replacement satellites.

Orbital-use fees could also help satellite operators get ahead of the space junk problem. “In other sectors, addressing the Tragedy of the Commons has often been a game of catch-up with substantial social costs. But the relatively young space industry can avoid these costs before they escalate,” Burgess said.

Here’s a link to and a citation for the paper,

Orbital-use fees could more than quadruple the value of the space industry by Akhil Rao, Matthew G. Burgess, and Daniel Kaffine. DOI: PNAS first published May 26, 2020

This paper is behind a paywall.

Clean up oil spills with a smart sponge?

I love the part with the magnet,

All of the main points are made in the video but for those who like text, there’s a May 28, 2020 news item on describing this new smart sponge for cleaning up oil spills (Note: Links have been removed),

A Northwestern University-led [Chicago, Illinois, US] team has developed a highly porous smart sponge that selectively soaks up oil in water.

With an ability to absorb more than 30 times its weight in oil, the sponge could be used to inexpensively and efficiently clean up oil spills without harming marine life. After squeezing the oil out of the sponge, it can be reused many dozens of times without losing its effectiveness.

“Oil spills have devastating and immediate effects on the environment, human health and economy,” said Northwestern’s Vinayak Dravid, who led the research. “Although many spills are small and may not make the evening news, they are still profoundly invasive to the ecosystem and surrounding community. Our sponge can remediate these spills in a more economic, efficient and eco-friendly manner than any of the current state-of-the-art solutions.”

A May 28, 2020 Northwestern University news release (also on EurekAlert), which originated the news item, reveals (as did the video) the characteristics that make this smart sponge particularly interesting,

Oil spill clean-up is an expensive and complicated process that often harms marine life and further damages the environment. Currently used solutions include burning the oil, using chemical dispersants to breakdown oil into very small droplets, skimming oil floating on top of water and/or absorbing it with expensive, unrecyclable sorbents.

“Each approach has its own drawbacks and none are sustainable solutions,” Nandwana [Vikas Nandwana, a senior research associate in Dravid’s laboratory] said. “Burning increases carbon emissions and dispersants are terribly harmful for marine wildlife. Skimmers don’t work in rough waters or with thin layers of oil. And sorbents are not only expensive, but they generate a huge amount of physical waste — similar to the diaper landfill issue.”

The Northwestern solution bypasses these challenges by selectively absorbing oil and leaving clean water and unaffected marine life behind. The secret lies in a nanocomposite coating of magnetic nanostructures and a carbon-based substrate that is oleophilic (attracts oil), hydrophobic (resists water) and magnetic. The nanocomposite’s nanoporous 3D structure selectively interacts with and binds to the oil molecules, capturing and storing the oil until it is squeezed out. The magnetic nanostructures give the smart sponge two additional functionalities: controlled movement in the presence of an external magnetic field and desorption of adsorbed components, such as oil, in a simulated and remote manner.

The OHM (oleophilic hydrophobic magnetic) nanocomposite slurry can be used to coat any cheap, commercially available sponge. The researchers applied a thin coating of the slurry to the sponge, squeezed out the excess and let it dry. The sponge is quickly and easily converted into a smart sponge (or “OHM sponge”) with a selective affinity for oil.

Vinayak and his team tested the OHM sponge with many different types of crude oils of varying density and viscosity. The OHM sponge consistently absorbed up to 30 times its weight in oil, leaving the water behind. To mimic natural waves, researchers put the OHM sponge on a shaker submerged in water. Even after vigorous shaking, the sponge release less than 1% of its absorbed oil back into the water.

“Our sponge works effectively in diverse and extreme aquatic conditions that have different pH and salinity levels,” Dravid said. “We believe we can address a giga-ton problem with a nanoscale solution.”

“We are excited to introduce such smart sponges as an environmental remediation platform for selectively removing and recovering pollutants present in water, soil and air, such as excess nutrients, heavy metal contaminants, VOC/toxins and others,” Nandwana said. “The nanostructure coating can be tailored to selectively adsorb (and later desorb) these pollutants.”

The team also is working on another grade of OHM sponge that can selectively absorb (and later recover) excess dissolved nutrients, such as phosphates, from fertilizer runoff and agricultural pollution. Stephanie Ribet, a Ph.D. candidate in Dravid’s lab and paper coauthor is pursuing this topic. The team plans to develop and commercialize OHM technology for environmental clean-up.

Bravo to professor Vinayak Dravid and his team. I’m sure I’m not alone in wishing you and your team the best of luck as you continue to develop this remediation technology.

Here’s a link to and a citation for the paper,

OHM Sponge: A Versatile, Efficient, and Ecofriendly Environmental Remediation Platform by Vikas Nandwana, Stephanie M. Ribet, Roberto D. Reis, Yuyao Kuang, Yash More, and Vinayak P. Dravid. Ind. Eng. Chem. Res. 2020, XXXX, XXX, XXX-XXX DOI: Publication Date:May 12, 2020 Copyright © 2020 American Chemical Society

This paper is behind a paywall.

Tiny sponges lure coronavirus away from lung cells

This research approach looks promising as three news releases trumpeting the possibilities indicate. First, there’s the June 17, 2020 American Chemical Society (ACS) news release,

Scientists are working overtime to find an effective treatment for COVID-19, the illness caused by the new coronavirus, SARS-CoV-2. Many of these efforts target a specific part of the virus, such as the spike protein. Now, researchers reporting in Nano Letters have taken a different approach, using nanosponges coated with human cell membranes –– the natural targets of the virus –– to soak up SARS-CoV-2 and keep it from infecting cells in a petri dish.

To gain entry, SARS-CoV-2 uses its spike protein to bind to two known proteins on human cells, called ACE2 and CD147. Blocking these interactions would keep the virus from infecting cells, so many researchers are trying to identify drugs directed against the spike protein. Anthony Griffiths, Liangfang Zhang and colleagues had a different idea: making a nanoparticle decoy with the virus’ natural targets, including ACE2 and CD147, to lure SARS-CoV-2 away from cells. And to test this idea, they conducted experiments with the actual SARS-CoV-2 virus in a biosafety level 4 lab.

The researchers coated a nanoparticle polymer core with cell membranes from either human lung epithelial cells or macrophages –– two cell types infected by SARS-CoV-2. They showed that the nanosponges had ACE2 and CD147, as well as other cell membrane proteins, projecting outward from the polymer core. When administered to mice, the nanosponges did not show any short-term toxicity. Then, the researchers treated cells in a dish with SARS-CoV-2 and the lung epithelial or macrophage nanosponges. Both decoys neutralized SARS-CoV-2 and prevented it from infecting cells to a similar extent. The researchers plan to next test the nanosponges in animals before moving to human clinical trials. In theory, the nanosponge approach would work even if SARS-CoV-2 mutates to resist other therapies, and it could be used against other viruses, as well, the researchers say.

In this illustration, a nanosponge coated with a human cell membrane acts as a decoy to prevent a virus from entering cells. Credit: Adapted from Nano Letters 2020, DOI: 10.1021/acs.nanolett.0c02278

There are two research teams involved, one at Boston University and the other at the University of California at San Diego (UC San Diego or UCSD). The June 18, 2020 Boston University news release (also on EurekAlert) by Kat J. McAlpine adds more details about the research, provides some insights from the researchers, and is a little redundant if you’ve already seen the ACS news release,

Imagine if scientists could stop the coronavirus infection in its tracks simply by diverting its attention away from living lung cells? A new therapeutic countermeasure, announced in a Nano Letters study by researchers from Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) and the University of California San Diego, appears to do just that in experiments that were carried out at the NEIDL in Boston.

The breakthrough technology could have major implications for fighting the SARS-CoV-2 virus responsible for the global pandemic that’s already claimed nearly 450,000 lives and infected more than 8 million people. But, perhaps even more significantly, it has the potential to be adapted to combat virtually any virus, such as influenza or even Ebola.

“I was skeptical at the beginning because it seemed too good to be true,” says NEIDL microbiologist Anna Honko, one of the co-first authors on the study. “But when I saw the first set of results in the lab, I was just astonished.”

The technology consists of very small, nanosized drops of polymers–essentially, soft biofriendly plastics–covered in fragments of living lung cell and immune cell membranes.

“It looks like a nanoparticle coated in pieces of cell membrane,” Honko says. “The small polymer [droplet] mimics a cell having a membrane around it.”

The SARS-CoV-2 virus seeks out unique signatures of lung cell membranes and latches onto them. When that happens inside the human body, the coronavirus infection takes hold, with the SARS-CoV-2 viruses hijacking lung cells to replicate their own genetic material. But in experiments at the NEIDL, BU researchers observed that polymer droplets laden with pieces of lung cell membrane did a better job of attracting the SARS-CoV-2 virus than living lung cells. [emphasis mine]

By fusing with the SARS-CoV-2 virus better than living cells can, the nanotechnology appears to be an effective countermeasure to coronavirus infection, preventing SARS-CoV-2 from attacking cells.

“Our guess is that it acts like a decoy, it competes with cells for the virus,” says NEIDL microbiologist Anthony Griffiths, co-corresponding author on the study. “They are little bits of plastic, just containing the outer pieces of cells with none of the internal cellular machinery contained inside living cells. Conceptually, it’s such a simple idea. It mops up the virus like a sponge.”

That attribute is why the UC San Diego and BU research team call the technology “nanosponges.” Once SARS-CoV-2 binds with the cell fragments inside a nanosponge droplet–each one a thousand times smaller than the width of a human hair–the coronavirus dies. Although the initial results are based on experiments conducted in cell culture dishes, the researchers believe that inside a human body, the biodegradable nanosponges and the SARS-CoV-2 virus trapped inside them could then be disposed of by the body’s immune system. The immune system routinely breaks down and gets rid of dead cell fragments caused by infection or normal cell life cycles.

There is also another important effect that the nanosponges have in the context of coronavirus infection. Honko says nanosponges containing fragments of immune cells can soak up cellular signals that increase inflammation [emphases mine]. Acute respiratory distress, caused by an inflammatory cascade inside the lungs, is the most deadly aspect of the coronavirus infection, sending patients into the intensive care unit for oxygen or ventilator support to help them breathe.

But the nanosponges, which can attract the inflammatory molecules that send the immune system into dangerous overdrive, can help tamp down that response, Honko says. By using both kinds of nanosponges, some containing lung cell fragments and some containing pieces of immune cells, she says it’s possible to “attack the coronavirus and the [body’s] response” responsible for disease and eventual lung failure.

At the NEIDL, Honko and Griffiths are now planning additional experiments to see how well the nanosponges can prevent coronavirus infection in animal models of the disease. They plan to work closely with the team of engineers at UC San Diego, who first developed the nanosponges more than a decade ago, to tailor the technology for eventual safe and effective use in humans.

“Traditionally, drug developers for infectious diseases dive deep on the details of the pathogen in order to find druggable targets,” said Liangfang Zhang, a UC San Diego nanoengineer and leader of the California-based team, according to a UC San Diego press release. “Our approach is different. We only need to know what the target cells are. And then we aim to protect the targets by creating biomimetic decoys.”

When the novel coronavirus first appeared, the idea of using the nanosponges to combat the infection came to Zhang almost immediately. He reached out to the NEIDL for help. Looking ahead, the BU and UC San Diego collaborators believe the nanosponges can easily be converted into a noninvasive treatment.

“We should be able to drop it right into the nose,” Griffiths says. “In humans, it could be something like a nasal spray.”

Honko agrees: “That would be an easy and safe administration method that should target the appropriate [respiratory] tissues. And if you wanted to treat patients that are already intubated, you could deliver it straight into the lung.”

Griffiths and Honko are especially intrigued by the nanosponges as a new platform for treating all types of viral infections. “The broad spectrum aspect of this is exceptionally appealing,” Griffiths says. The researchers say the nanosponge could be easily adapted to house other types of cell membranes preferred by other viruses, creating many new opportunities to use the technology against other tough-to-treat infections like the flu and even deadly hemorrhagic fevers caused by Ebola, Marburg, or Lassa viruses.

“I’m interested in seeing how far we can push this technology,” Honko says.

The University of California as San Diego has released a video illustrating the nanosponges work,

There’s also this June 17, 2020 University of California at San Diego (UC San Diego) news release (also on EurekAlert) by Ioana Patringenaru, which offers extensive new detail along with, if you’ve read one or both of the news releases in the above, a few redundant bits,

Nanoparticles cloaked in human lung cell membranes and human immune cell membranes can attract and neutralize the SARS-CoV-2 virus in cell culture, causing the virus to lose its ability to hijack host cells and reproduce.

The first data describing this new direction for fighting COVID-19 were published on June 17 in the journal Nano Letters. The “nanosponges” were developed by engineers at the University of California San Diego and tested by researchers at Boston University.

The UC San Diego researchers call their nano-scale particles “nanosponges” because they soak up harmful pathogens and toxins.

In lab experiments, both the lung cell and immune cell types of nanosponges caused the SARS-CoV-2 virus to lose nearly 90% of its “viral infectivity” in a dose-dependent manner. Viral infectivity is a measure of the ability of the virus to enter the host cell and exploit its resources to replicate and produce additional infectious viral particles.

Instead of targeting the virus itself, these nanosponges are designed to protect the healthy cells the virus invades.

“Traditionally, drug developers for infectious diseases dive deep on the details of the pathogen in order to find druggable targets. Our approach is different. We only need to know what the target cells are. And then we aim to protect the targets by creating biomimetic decoys,” said Liangfang Zhang, a nanoengineering professor at the UC San Diego Jacobs School of Engineering.

His lab first created this biomimetic nanosponge platform more than a decade ago and has been developing it for a wide range of applications ever since [emphasis mine]. When the novel coronavirus appeared, the idea of using the nanosponge platform to fight it came to Zhang “almost immediately,” he said.

In addition to the encouraging data on neutralizing the virus in cell culture, the researchers note that nanosponges cloaked with fragments of the outer membranes of macrophages could have an added benefit: soaking up inflammatory cytokine proteins, which are implicated in some of the most dangerous aspects of COVID-19 and are driven by immune response to the infection.

Making and testing COVID-19 nanosponges

Each COVID-19 nanosponge–a thousand times smaller than the width of a human hair–consists of a polymer core coated in cell membranes extracted from either lung epithelial type II cells or macrophage cells. The membranes cover the sponges with all the same protein receptors as the cells they impersonate–and this inherently includes whatever receptors SARS-CoV-2 uses to enter cells in the body.

The researchers prepared several different concentrations of nanosponges in solution to test against the novel coronavirus. To test the ability of the nanosponges to block SARS-CoV-2 infectivity, the UC San Diego researchers turned to a team at Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) to perform independent tests. In this BSL-4 lab–the highest biosafety level for a research facility–the researchers, led by Anthony Griffiths, associate professor of microbiology at Boston University School of Medicine, tested the ability of various concentrations of each nanosponge type to reduce the infectivity of live SARS-CoV-2 virus–the same strains that are being tested in other COVID-19 therapeutic and vaccine research.

At a concentration of 5 milligrams per milliliter, the lung cell membrane-cloaked sponges inhibited 93% of the viral infectivity of SARS-CoV-2. The macrophage-cloaked sponges inhibited 88% of the viral infectivity of SARS-CoV-2. Viral infectivity is a measure of the ability of the virus to enter the host cell and exploit its resources to replicate and produce additional infectious viral particles.

“From the perspective of an immunologist and virologist, the nanosponge platform was immediately appealing as a potential antiviral because of its ability to work against viruses of any kind. This means that as opposed to a drug or antibody that might very specifically block SARS-CoV-2 infection or replication, these cell membrane nanosponges might function in a more holistic manner in treating a broad spectrum of viral infectious diseases. I was optimistically skeptical initially that it would work, and then thrilled once I saw the results and it sunk in what this could mean for therapeutic development as a whole,” said Anna Honko, a co-first author on the paper and a Research Associate Professor, Microbiology at Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL).

In the next few months, the UC San Diego researchers and collaborators will evaluate the nanosponges’ efficacy in animal models. The UC San Diego team has already shown short-term safety in the respiratory tracts and lungs of mice. If and when these COVID-19 nanosponges will be tested in humans depends on a variety of factors, but the researchers are moving as fast as possible.

“Another interesting aspect of our approach is that even as SARS-CoV-2 mutates, as long as the virus can still invade the cells we are mimicking, our nanosponge approach should still work. I’m not sure this can be said for some of the vaccines and therapeutics that are currently being developed,” said Zhang.

The researchers also expect these nanosponges would work against any new coronavirus or even other respiratory viruses, including whatever virus might trigger the next respiratory pandemic.

Mimicking lung epithelial cells and immune cells

Since the novel coronavirus often infects lung epithelial cells as the first step in COVID-19 infection, Zhang and his colleagues reasoned that it would make sense to cloak a nanoparticle in fragments of the outer membranes of lung epithelial cells to see if the virus could be tricked into latching on it instead of a lung cell.

Macrophages, which are white blood cells that play a major role in inflammation, also are very active in the lung during the course of a COVID-19 illness, so Zhang and colleagues created a second sponge cloaked in macrophage membrane.

The research team plans to study whether the macrophage sponges also have the ability to quiet cytokine storms in COVID-19 patients.

“We will see if the macrophage nanosponges can neutralize the excessive amount of these cytokines as well as neutralize the virus,” said Zhang.

Using macrophage cell fragments as cloaks builds on years of work to develop therapies for sepsis using macrophage nanosponges.

In a paper published in 2017 in Proceedings of the National Academy of Sciences, Zhang and a team of researchers at UC San Diego showed that macrophage nanosponges can safely neutralize both endotoxins and pro-inflammatory cytokines in the bloodstream of mice. A San Diego biotechnology company co-founded by Zhang called Cellics Therapeutics is working to translate this macrophage nanosponge work into the clinic.

A potential COVID-19 therapeutic The COVID-19 nanosponge platform has significant testing ahead of it before scientists know whether it would be a safe and effective therapy against the virus in humans, Zhang cautioned [emphasis mine]. But if the sponges reach the clinical trial stage, there are multiple potential ways of delivering the therapy that include direct delivery into the lung for intubated patients, via an inhaler like for asthmatic patients, or intravenously, especially to treat the complication of cytokine storm.

A therapeutic dose of nanosponges might flood the lung with a trillion or more tiny nanosponges that could draw the virus away from healthy cells. Once the virus binds with a sponge, “it loses its viability and is not infective anymore, and will be taken up by our own immune cells and digested,” said Zhang.

“I see potential for a preventive treatment, for a therapeutic that could be given early because once the nanosponges get in the lung, they can stay in the lung for some time,” Zhang said. “If a virus comes, it could be blocked if there are nanosponges waiting for it.”

Growing momentum for nanosponges

Zhang’s lab at UC San Diego created the first membrane-cloaked nanoparticles over a decade ago. The first of these nanosponges were cloaked with fragments of red blood cell membranes. These nanosponges are being developed to treat bacterial pneumonia and have undergone all stages of pre-clinical testing by Cellics Therapeutics, the San Diego startup cofounded by Zhang. The company is currently in the process of submitting the investigational new drug (IND) application to the FDA for their lead candidate: red blood cell nanosponges for the treatment of methicillin-resistant staphylococcus aureus (MRSA) pneumonia. The company estimates the first patients in a clinical trial will be dosed next year.

The UC San Diego researchers have also shown that nanosponges can deliver drugs to a wound site; sop up bacterial toxins that trigger sepsis; and intercept HIV before it can infect human T cells.

The basic construction for each of these nanosponges is the same: a biodegradable, FDA-approved polymer core is coated in a specific type of cell membrane, so that it might be disguised as a red blood cell, or an immune T cell or a platelet cell. The cloaking keeps the immune system from spotting and attacking the particles as dangerous invaders.

“I think of the cell membrane fragments as the active ingredients. This is a different way of looking at drug development,” said Zhang. “For COVID-19, I hope other teams come up with safe and effective therapies and vaccines as soon as possible. At the same time, we are working and planning as if the world is counting on us.”

I wish the researchers good luck. For the curious, here’s a link to and a citation for the paper,

Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity by Qiangzhe Zhang, Anna Honko, Jiarong Zhou, Hua Gong, Sierra N. Downs, Jhonatan Henao Vasquez, Ronnie H. Fang, Weiwei Gao, Anthony Griffiths, and Liangfang Zhang. Nano Lett. 2020, XXXX, XXX, XXX-XXX DOI: Publication Date:June 17, 2020 Copyright © 2020 American Chemical Society

This paper appears to be open access.

Here, too, is the Cellics Therapeutics website.

Sunscreens 2020 and the Environmental Working Group (EWG)

There must be some sweet satisfaction or perhaps it’s better described as relief for the Environmental Working Group (EWG) now that sunscreens with metallic (zinc oxide and/or titanium dioxide) nanoparticles are gaining wide acceptance. (More about the history and politics EWG and metallic nanoparticles at the end of this posting.)

This acceptance has happened alongside growing concerns about oxybenzone, a sunscreen ingredient that EWG has long warned against. Oxybenzone has been banned from use in Hawaii due to environmental concerns (see my July 6, 2018 posting; scroll down about 40% of the way for specifics about Hawaii). Also, it is one of the common sunscreen ingredients for which the US Food and Drug Administration (FDA) is completing a safety review.

Today, zinc oxide and titanium dioxide metallic nanoparticles are being called minerals, as in, “mineral-based” sunscreens. They are categorized as physical sunscreens as opposed to chemical sunscreens.

I believe the most recent sunscreen posting here was my 2018 update (uly 6, 2018 posting) so the topic is overdue for some attention here. From a May 21, 2020 EWG news release (received via email),

As states reopen and Americans leave their homes to venture outside, it’s important for them to remember to protect their skin from the sun’s harmful rays. Today the Environmental Working Group released its 14th annual Guide to Sunscreens.  

This year researchers rated the safety and efficacy of more than 1,300 SPF products – including sunscreens, moisturizers and lip balms – and found that only 25 percent offer adequate protection and do not contain worrisome ingredients such as oxybenzone, a potential hormone-disrupting chemical that is readily absorbed by the body.

Despite a delay in finalizing rules that would make all sunscreens on U.S. store shelves safer, the Food and Drug Administration, the agency that governs sunscreen safety, is completing tests that highlight concerns with common sunscreen ingredients. Last year, the agency published two studies showing that, with just a single application, six commonly used chemical active ingredients, including oxybenzone, are readily absorbed through the skin and could be detected in our bodies at levels that could cause harm.

“It’s quite concerning,” said Nneka Leiba, EWG’s vice president of Healthy Living science. “Those studies don’t prove whether the sunscreens are unsafe, but they do highlight problems with how these products are regulated.”

“EWG has been advocating for the FDA to review these chemical ingredients for 14 years,” Leiba said. “We slather these ingredients on our skin, but these chemicals haven’t been adequately tested. This is just one example of the backward nature of product regulation in the U.S.”

Oxybenzone remains a commonly used active ingredient, found in more than 40 percent of the non-mineral sunscreens in this year’s guide. Oxybenzone is allergenic and a potential endocrine disruptor, and has been detected in human breast milk, amniotic fluid, urine and blood.

According to EWG’s assessment, fewer than half of the products in this year’s guide contain active ingredients that the FDA has proposed are safe and effective.

“Based on the best current science and toxicology data, we continue to recommend sunscreens with the mineral active ingredients zinc dioxide and titanium dioxide, because they are the only two ingredients the FDA recognized as safe or effective in their proposed draft rules,” said Carla Burns, an EWG research and database analyst who manages the updates to the sunscreen guide.

Most people select sunscreen products based on their SPF, or sunburn protection factor, and mistakenly assume that bigger numbers offer better protection. According to the FDA, higher SPF values have not been shown to provide additional clinical benefit and may give users a false sense of protection. This may lead to overexposure to UVA rays that increase the risk of long-term skin damage and cancer. The FDA has proposed limiting SPF claims to 60+.

EWG continues to hone our recommendations by strengthening the criteria for assessing sunscreens, which are based on the latest findings in the scientific literature and commissioned tests of sunscreen product efficacy. This year EWG made changes to our methodology in order to strengthen our requirement that products provide the highest level of UVA protection.

“Our understanding of the dangers associated with UVA exposure is increasing, and they are of great concern,” said Burns. “Sunburn during early life, especially childhood, is very dangerous and a risk factor for all skin cancers, but especially melanoma. Babies and young children are especially vulnerable to sun damage. Just a few blistering sunburns early in life can double a person’s risk of developing melanoma later in life.”

EWG researchers found 180 sunscreens that meet our criteria for safety and efficacy and would likely meet the proposed FDA standards. Even the biggest brands now provide mineral options for consumers.  

Even for Americans continuing to follow stay-at-home orders, wearing an SPF product may still be important. If you’re sitting by a window, UVA and UVB rays can penetrate the glass.  

It is important to remember that sunscreen is only one part of a sun safety routine. People should also protect their skin by covering up with clothing, hats and sunglasses. And sunscreen must be reapplied at least every two hours to stay effective.

EWG’s Guide to Sunscreens helps consumers find products that get high ratings for providing adequate broad-spectrum protection and that are made with ingredients that pose fewer health concerns.

The new guide also includes lists of:

Here are more quick tips for choosing better sunscreens:

  • Check your products in EWG’s sunscreen database and avoid those with harmful ingredients.
  • Avoid products with oxybenzone. This chemical penetrates the skin, gets into the bloodstream and can affect normal hormone activities.
  • Steer clear of products with SPF higher than 50+. High SPF values do not necessarily provide increased UVA protection and may fool you into thinking you are safe from sun damage.
  • Avoid sprays. These popular products pose inhalation concerns, and they may not provide a thick and uniform coating on the skin.
  • Stay away from retinyl palmitate. Government studies link the use of retinyl palmitate, a form of vitamin A, to the formation of skin tumors and lesions when it is applied to sun-exposed skin.
  • Avoid intense sun exposure during the peak hours of 10 a.m. to 4 p.m.

Shoppers on the go can download EWG’s Healthy Living app to get ratings and safety information on sunscreens and other personal care products. Also be sure to check out EWG’s sunscreen label decoder.

One caveat, these EWG-recommended products might not be found in Canadian stores or your favourite product may not have been reviewed for inclusion, as a product to be sought out or avoided, in their database. For example, I use a sunscreen that isn’t listed in the database, although at least a few other of the company’s sunscreen products are. On the plus side, my sunscreen doesn’t include oxybenzone or retinyl palmitate as ingredients.

To sum up the situation with sunscreens containing metallic nanoparticles (minerals), they are considered to be relatively safe but should new research emerge that designation could change. In effect, all we can do is our best with the information at hand.

History and politics of metallic nanoparticles in sunscreens

In 2009 it was a bit of a shock when the EWG released a report recommending the use of sunscreens with metallic nanoparticles in the list of ingredients. From my July 9, 2009 posting,

The EWG (Environmental Working Group) is, according to Maynard [as of 20202: Dr. Andrew Maynard is a scientist and author, Associate Director of Faculty in the ASU {Arizona State University} School for the Future of Innovation in Society, also the director of the ASU Risk Innovation Lab, and leader of the Risk Innovation Nexus], not usually friendly to industry and they had this to say about their own predisposition prior to reviewing the data (from EWG),

When we began our sunscreen investigation at the Environmental Working Group, our researchers thought we would ultimately recommend against micronized and nano-sized zinc oxide and titanium dioxide sunscreens. After all, no one has taken a more expansive and critical look than EWG at the use of nanoparticles in cosmetics and sunscreens, including the lack of definitive safety data and consumer information on these common new ingredients, and few substances more dramatically highlight gaps in our system of public health protections than the raw materials used in the burgeoning field of nanotechnology. But many months and nearly 400 peer-reviewed studies later, we find ourselves drawing a different conclusion, and recommending some sunscreens that may contain nano-sized ingredients.

My understanding is that after this report, the EWG was somewhat ostracized by collegial organizations. Friends of the Earth (FoE) and the ETC Group both of which issued reports that were published after the EWG report and were highly critical of ‘nano sunscreens’.

The ETC Group did not continue its anti nanosunscreen campaign for long (I saw only one report) but FoE (in particular the Australian arm of the organization) more than made up for that withdrawal and to sad effect. My February 9, 2012 post title was this: Unintended consequences: Australians not using sunscreens to avoid nanoparticles?

An Australian government survey found that 13% of Australians were not using any sunscreen due to fears about nanoparticles. In a country with the highest incidence of skin cancer in the world and, which spent untold millions over decades getting people to cover up in the sun, it was devastating news.

FoE immediately withdrew all their anti nanosunscreen materials in Australia from circulation while firing broadsides at the government. The organization’s focus on sunscreens with metallic nanoparticles has diminished since 2012.


I have difficulty trusting materials from FoE and you can see why here in this July 26, 2011 posting (Misunderstanding the data or a failure to research? Georgia Straight article about nanoparticles). In it, I analyze Alex Roslin’s profoundly problematic article about metallic nanoparticles and other engineered nanoparticles. All of Roslin’s article was based on research and materials produced by FoE which misrepresented some of the research. Roslin would have realized that if he had bothered to do any research for himself.

EWG impressed me mightily with their refusal to set aside or dismiss the research disputing their initial assumption that metallic nanoparticles in sunscreens were hazardous. (BTW, there is one instance where metallic nanoparticles in sunscreens are of concern. My October 13, 2013 posting about anatase and rutile forms of titanium dioxide at the nanoscale features research on that issue.)

EWG’s Wikipedia entry

Whoever and however many are maintaining this page, they don’t like EWG at all,

The accuracy of EWG reports and statements have been criticized, as has its funding by the organic food industry[2][3][4][5] Its warnings have been labeled “alarmist”, “scaremongering” and “misleading”.[6][7][8] Despite the questionable status of its work, EWG has been influential.[9]

This is the third paragraph in the Introduction. At its very best, the information is neutral, otherwise, it’s much like that third paragraph.

Even John D. Rockeller’s entry is more flattering and he was known as the ‘most hated man in America’ as this show description on the Public Broadcasting Service (PBS) website makes clear,

American Experience

The Rockefellers Chapter One

Clip: Season 13 Episode 1 | 9m 37s

John D. Rockefeller was the world’s first billionaire and the most hated man in America. Watch the epic story of the man who monopolized oil.

Fun in the sun

Have fun in the sun this summer. There’s EWG’s sunscreen database, the tips listed in the news release, and EWG also has a webpage where they describe their methodology for how they assess sunscreens. It gets a little technical (for me anyway) but it should answer any further safety questions you might have after reading this post.

It may require a bit of ingenuity given the concerns over COVID-19 but I’m constantly amazed at the inventiveness with which so many people have met this pandemic. (This June 15, 2020 Canadian Broadcasting Corporation article by Sheena Goodyear features a family that created a machine that won the 2020 Rube Goldberg Bar of Soap Video challenge. The article includes an embedded video of the winning machine in action.)

ISEA (International Symposium on Electronic Arts) 2020: Why Sentience? still in October 2020 but virtually in Montréal, Québec

I wonder what happens to geography and time when you hold your conference virtually? Part of the excitement of a conference or other meetings is the promise of the destination with new people and new adventures. Whether 2020 is a pause between in-person meetings, a moment when everything changed, or some combination is yet to be determined but perhaps ISEA2020 will be a harbinger.

I received a June 10, 2020 notice (via email) with the latest news about ISEA2020,

Montreal, June 10, 2020    ISEA2020 from October 13 to 18, 2020 goes entirely digital, with an innovative experiential format.

The worldwide COVID-19 outbreak has forced ISEA2020 in Montreal to be postponed to October 13 to 18. The physical distancing measures put in place in many countries and the travel restrictions imposed to prevent the spread of the pandemic mean that we cannot all be physically present in Montreal. Montreal Digital Spring (Printemps numérique) – the organizers of ISEA2020 –  have thus decided to make the symposium a 100% online event. Our team is currently working on the platform that will allow us to come together, connect, and exchange knowledge and practices, despite the physical distance. We worked with our partners and collaborators, experts in art, design, science and technology to (if only begin to) reinvent the format of academic interdisciplinary conferencing! 

Our main strategies for ISEA2020 Online:

Programming: ISEA2020 is a full week of research and creation, 100% online, with more than 300 international speakers and artists from over 40 countries.

Connecting: We are working on the online platform to ensure we meet ISEA’s core values of encouraging and promoting creative exchanges between diverse groups; of creating opportunities for networking and informal meetings, in addition to ensuring the good flow of panel sessions.

Programming for all the time-zones: From October 13 to 16, conference presentations will unfold over 16 consecutive hours each day, in order to include participants in all the time zones, from East Asia to the west Americas.

Reduced registration fee: The registration fee has been reduced. In addition to saving travel costs, ISEA2020 Online is accessible at a significantly reduced fee, hoping it will attract a larger number of participants, including more students and independent artists. 

Live Q&A: All presentation sessions, including keynote sessions, will include live Q&A periods, mediated by invited delegates.

Art Programming:  We are working with artists and partners on strategies to showcase the selected projects and special programming.

While we regret not seeing you in Montreal, the new format will make ISEA2020 accessible to a larger number and will certainly contribute to a broader discussion on how to produce and transfer knowledge and showcase art through connected digital communication platforms. Our team is committed to ensuring the high standard of creative and academic contributions that is paramount to ISEA.

We look forward to seeing you online this fall!


You can now purchase your ISEA2020 Online Pass at the Early Bird rates of CAD $99 (regular) and CAD $69 (students), offer valid until August 13 [2020].


The deadline to register, to upload the camera-ready papers, and to fill in the Zone Festival form is July 27 at 11:59 pm (GMT-5). 


We updated our website. Please refer to the Frequently Asked Questions – FAQ page. If you have a specific question, please contact: for academic presentations / for artworks / for general questions/registration. 


How we got here

The academic chairs have written this statement,

OCTOBER 13-18, 2020

The academic chairs’ statements regarding the ISEA2020 online turn:

Since last August [2019] when we established the ISEA2020 theme of “Why Sentience?”, life on Earth has been dramatically transformed. Our belief in concepts like proximity, justice, equality, indeed, the very concept of the future itself, has been radically uprooted. As cultural organizations worldwide scramble to adapt, the ISEA2020 team has decided to reimagine the event for the anytime/anyplace zone of digital space and to transform it into an online experience. But we have also realized that there is no need to adjust the theme to make it more “responsive” to our current conditions. Despite their almost cataclysmic impact on the political-economic-social-cultural-ecological fabric of the world, the triumvirate forces of the coronavirus pandemic, its disastrous economic consequences, as well as systemic racial injustice have now acutely amplified ISEA2020s question: “Why Sentience?” These conditions sharpen the need to stop, pause and re-examine what it means to be sentient, “the ability to feel or perceive.” They help us reformulate our notions of what the world is with us and beyond us. They give us a front seat perspective on the corporeal and ecological entanglements between power and knowledge, animals and humans, machines and environment, oppression and liberation. They pointedly demonstrate that difference—social-economic-cultural—resonates through the sentient world. The virus—a 120-160 nm in diameter entity that is invisible to our human senses and considered neither living nor dead but ontologically somewhere in between [emphasis mine]—is thus perversely a great teacher and provides us lessons on how the modern splitting up of the sentient and inanimate worlds increasingly makes no sense.

ISEA’s mission aims to foster interdisciplinary academic discourse and exchange among culturally diverse organizations and individuals working with art, science and technology. As we write, ISEA2020 should have already passed into history. The new digital space of ISEA2020 will link the local community in Montreal with the international one beyond so that we can collectively rethink the form of such an event. The new platform will also allow us to examine close up these new and, at the same time, ongoing historical set of conditions; conditions that demand a response if we are to live in the coming (post)-pandemic world. 

Christine Ross – McGill University (Montreal, Canada)

Chris Salter – Concordia University/Hexagram (Montreal, Canada)

2020 Trailers

There is a conference trailer for this new ‘virtual’ version of the 2020 conference,

Montreal Digital Spring (Printemps numérique) produced both the English language version and this one in French***, Note: Video [credit]: Guillaume Guardia,

I’m not sure why the French language version is so much shorter*** (maybe I found an abridged version?), in any case, the content is quite different and you may want to check out both trailers.

***ETA June 22, 2020 at 1550 PDT: The answer to my question as to why one trailer was shorter? Two different (but this year related) events. I failed to note that the second trailer was for “MTL Connect.” Here is Manuelle Freire’s description (academic programme manager of ISEA2020, Printemps numerique) of MTL Connect,

The latter is an annual event organised in Montreal by Printemps numérique, consisting of different thematic pavilion. This year ISEA2020 is the art and creativity pavilion of MTL Connect, so part of a larger endeavour that is affected by this online turn in its entirety.

As for MTL Connect, there’s this from the homepage,



That’s it for the correction. ***

Meeting technology, cyber security, and local involvement

I emailed (Friday, June 19, 2020) a couple of questions to the organizers which they have kindly answered.

  1. Are you going to be using Zoom as the technology for virtual
    attendance? Will there be security measures for attendees?
  2. [A]re there going to be any local (Vancouver, BC) virtual or in-person get-togethers? By October it might be possible to have small groups (with appropriate precautions) meet in person for ISEA2020 discussions/participation in virtual events held elsewhere. (Just a thought)

They responded by Sunday, June 21, 2020). That is quickly. The short answer to both questions is: “We don’t know yet.”

More specifically, Manuelle Freire (Printemps numerique) had this to say,

I will have to forward your first question regarding the technology of the platform, specifically cybersecurity, to the platform development project manager. Cybersecurity is an important matter that we have discussed internally and will be included in the FAQ and the IEA2020, as soon as we have stabilized the different features of the platform and we are ready to release.

As for the second question,

In what comes to small groups meeting in person. It is indeed possible that groups [might] be able to meet in October [2020], but at this stage, with social distancing and travel restrictions in place, we are still facing degrees of uncertainty. While we regret not meeting everyone in Montréal, moving the symposium 100% online seemed the only safe and certain solution. No in-person activities are scheduled for now.

The questions were also sent to Philippe Pasquier, a locally based (Vancouver, BC) member of the ISEA2020 academic committee and he had this to say about the possibility of local, in-person get-togethers,

As for (2), this is a good idea. Let’s wait and see what will be possible and revisit this idea closer to the date. 

The responses have made me happy. Hearing that they take cybersecurity seriously is downright musical and learning that they are open to local, small, in person get-togethers is spirit-lifting.

Final words

In 2009, I attended an ISEA being held in Northern Ireland and Ireland and asked one of the organizers if any of their symposia had been held in Canada. Yes! Montréal, my source raved at length, hosted a great meeting.

The next Canadian ISEA host was Vancouver in 2015 and guess what? Someone in a lineup was raving about the Montréal meeting. It seems that 1995 meeting has taken on a legendary glow.

It was a privilege being able to attend two meetings in person. Legendary, problematic, or good, the meetings bring together exciting talent and disturbing and/or mind-expanding ideas and experiences. Given the circumstances, the organizers find themselves dealing with, I wish them the best of luck although I’m confident that despite all the obstacles, ISEA2020 will be an extraordinary affair.

On a practical note, the $99 (or less) fee for the online pass is a good deal. (I know because I had to pay for mine when they were here in Vancouver in 2015. By the way, I’ve never regretted a penny of it.)